114 related articles for article (PubMed ID: 21919695)
1. Stereotactic body radiation therapy for prostate cancer.
Ishiyama H; Teh BS; Lo SS; Mathews T; Blanco A; Amato R; Ellis RJ; Mayr NA; Paulino AC; Xu B; Butler BE
Future Oncol; 2011 Sep; 7(9):1077-86. PubMed ID: 21919695
[TBL] [Abstract][Full Text] [Related]
2. The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer: A Comparison of Dose Regimens and Delivery Systems.
Sharieff W; Greenspoon JN; Dayes I; Chow T; Wright J; Lukka H
Technol Cancer Res Treat; 2016 Feb; 15(1):171-8. PubMed ID: 24750007
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?
Zaorsky NG; Studenski MT; Dicker AP; Gomella L; Den RB
Cancer Treat Rev; 2013 May; 39(3):212-8. PubMed ID: 23218442
[TBL] [Abstract][Full Text] [Related]
4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy for prostate cancer.
Henderson DR; Tree AC; van As NJ
Clin Oncol (R Coll Radiol); 2015 May; 27(5):270-9. PubMed ID: 25707911
[TBL] [Abstract][Full Text] [Related]
6. Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review.
Arcangeli S; Scorsetti M; Alongi F
Crit Rev Oncol Hematol; 2012 Oct; 84(1):101-8. PubMed ID: 22257653
[TBL] [Abstract][Full Text] [Related]
7. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.
King CR; Brooks JD; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):877-82. PubMed ID: 21300474
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
[TBL] [Abstract][Full Text] [Related]
10. Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysis.
Malouff TD; Stross WC; Seneviratne DS; Waddle MR; May BC; Buskirk SJ; Tzou KS
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):349-355. PubMed ID: 31780782
[TBL] [Abstract][Full Text] [Related]
11. A clinical review on extreme hypofractionated stereotactic body radiation therapy for localized prostate cancer using nonrobotic linear accelerators.
Macias VA; Perez-Romasanta LA
Cancer Invest; 2014 Jun; 32(5):191-6. PubMed ID: 24654695
[TBL] [Abstract][Full Text] [Related]
12. Extreme Hypofractionation with SBRT in Localized Prostate Cancer.
Gómez-Aparicio MA; Valero J; Caballero B; García R; Hernando-Requejo O; Montero Á; Gómez-Iturriaga A; Zilli T; Ost P; López-Campos F; Couñago F
Curr Oncol; 2021 Aug; 28(4):2933-2949. PubMed ID: 34436023
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.
Jabbari S; Weinberg VK; Kaprealian T; Hsu IC; Ma L; Chuang C; Descovich M; Shiao S; Shinohara K; Roach M; Gottschalk AR
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):228-34. PubMed ID: 21183287
[TBL] [Abstract][Full Text] [Related]
14. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
Kaidar-Person O; Roach M; Créhange G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
[TBL] [Abstract][Full Text] [Related]
15. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group.
Chang UK; Cho WI; Kim MS; Cho CK; Lee DH; Rhee CH
Acta Oncol; 2012 May; 51(5):589-95. PubMed ID: 22414095
[TBL] [Abstract][Full Text] [Related]
16. Treatment of prostate cancer local recurrence after whole-gland cryosurgery with frameless robotic stereotactic body radiotherapy: initial experience.
Quarrier S; Katz A; Haas J
Clin Genitourin Cancer; 2013 Jun; 11(2):89-93. PubMed ID: 23063579
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model.
Lotan Y; Stanfield J; Cho LC; Sherwood JB; Abdel-Aziz KF; Chang CH; Forster K; Kabbani W; Hsieh JT; Choy H; Timmerman R
J Urol; 2006 May; 175(5):1932-6. PubMed ID: 16600801
[TBL] [Abstract][Full Text] [Related]
18. Current role of image-guided robotic radiosurgery (Cyberknife(®) ) for prostate cancer treatment.
Seisen T; Drouin SJ; Phé V; Parra J; Mozer P; Bitker MO; Cussenot O; Rouprêt M
BJU Int; 2013 May; 111(5):761-6. PubMed ID: 23368740
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
Teh BS; Ishiyama H; Mathews T; Xu B; Butler EB; Mayr NA; Lo SS; Lu JJ; Blanco AI; Paulino AC; Timmerman RD
Discov Med; 2010 Sep; 10(52):255-62. PubMed ID: 20875347
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]